The FDA’s Obstetrics Reproductive and Urologic Drugs Advisory Committee voted nearly unanimously to withdraw the approval of Covis’ preterm birth drug Makenna.
https://www.pharmalive.com/wp-content/uploads/2021/08/FDA-Slams-Sesen-Bio-with-CRL-for-Bladder-Cancer-Drug-BioSpace-8-17-21.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-10-20 09:30:422022-10-20 09:31:13FDA Adcomm votes 14-1 to pull Covis’ Makenna from the market
